seed
Stage
About
Vasa Therapeutics is a biopharmaceutical company developing therapeutics that target the pathophysiology of cardiovascular aging, including a lead MMP-2/9 inhibitor for heart failure with preserved ejection fraction and long-acting apelin analogs for peripheral artery disease, neuromuscular disorders, and sarcopenia.
Explore Vasa Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.